mepron
Generic: atovaquone
Labeler: glaxosmithkline llcDrug Facts
Product Profile
Brand Name
mepron
Generic Name
atovaquone
Labeler
glaxosmithkline llc
Dosage Form
SUSPENSION
Routes
Active Ingredients
atovaquone 750 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
0173-0547
Product ID
0173-0547_88051971-96da-4b1c-9e64-4a4b9c92f2bd
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA020500
Listing Expiration
2026-12-31
Marketing Start
1998-09-18
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
01730547
Hyphenated Format
0173-0547
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
mepron (source: ndc)
Generic Name
atovaquone (source: ndc)
Application Number
NDA020500 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 750 mg/5mL
Packaging
- 42 POUCH in 1 DOSE PACK (0173-0547-00) / 5 mL in 1 POUCH
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "88051971-96da-4b1c-9e64-4a4b9c92f2bd", "openfda": {"nui": ["N0000175482", "N0000175485"], "unii": ["Y883P1Z2LT"], "rxcui": ["211947", "308429"], "spl_set_id": ["b426b6bf-f07e-4580-97ae-dfca1ddf5b8f"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "42 POUCH in 1 DOSE PACK (0173-0547-00) / 5 mL in 1 POUCH", "package_ndc": "0173-0547-00", "marketing_start_date": "19980918"}], "brand_name": "MEPRON", "product_id": "0173-0547_88051971-96da-4b1c-9e64-4a4b9c92f2bd", "dosage_form": "SUSPENSION", "pharm_class": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "product_ndc": "0173-0547", "generic_name": "atovaquone", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "MEPRON", "active_ingredients": [{"name": "ATOVAQUONE", "strength": "750 mg/5mL"}], "application_number": "NDA020500", "marketing_category": "NDA", "marketing_start_date": "19980918", "listing_expiration_date": "20261231"}